Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients paying out of pocket.

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

And on Wednesday the maker of Wegovy, a similar weight-loss drug, announced that it, too, would offer direct-to-consumer ...

Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on Friday, March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File) Makers of the popular obesity ...

Zepbound (tirzepatide) is an FDA-approved medication for weight management. People need a prescription to buy this medication, and several telemedicine companies offer doctor-led prescription and ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for ... there’s no longer a shortage of weight-loss drugs that had allowed for alternatives ...

ELI LILLY CUTS PRICES FOR ZEPBOUND WEIGHT-LOSS DRUG AGAIN Lilly said its fourth location will expand the company's global manufacturing network for future injectable medicines. "Lilly's optimism ...

(CNN) — Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the ...

(KCTV) - Weight loss drugs may have more benefits than some ... researchers analyzed Mounjaro, Zepbound, Ozempic, and Wegovy. These drugs are typically used to treat diabetes and obesity but ...